118 related articles for article (PubMed ID: 17142737)
1. Regulatory roles of NKT cells in the induction and maintenance of cyclophosphamide-induced tolerance.
Iwai T; Tomita Y; Okano S; Shimizu I; Yasunami Y; Kajiwara T; Yoshikai Y; Taniguchi M; Nomoto K; Yasui H
J Immunol; 2006 Dec; 177(12):8400-9. PubMed ID: 17142737
[TBL] [Abstract][Full Text] [Related]
2. The immunoregulatory roles of natural killer T cells in cyclophosphamide-induced tolerance.
Iwai T; Tomita Y; Shimizu I; Kajiwara T; Onzuka T; Okano S; Yasunami Y; Yoshikai Y; Nomoto K; Tominaga R
Transplantation; 2007 Dec; 84(12):1686-95. PubMed ID: 18165782
[TBL] [Abstract][Full Text] [Related]
3. Antibody-mediated T-cell reduction or increased levels of chimerism overcome resistance to cyclophosphamide-induced tolerance in NKT-deficient mice.
Onzuka T; Tomita Y; Okano S; Shimizu I; Yamada H; Yoshikai Y; Tominaga R
Scand J Immunol; 2010 Aug; 72(2):106-17. PubMed ID: 20618769
[TBL] [Abstract][Full Text] [Related]
4. Mixed chimerism, heart, and skin allograft tolerance in cyclophosphamide-induced tolerance.
Zhang QW; Tomita Y; Matsuzaki G; Yoshikawa M; Shimizu I; Nakashima Y; Sueishi K; Nomoto K; Yasui H
Transplantation; 2000 Sep; 70(6):906-16. PubMed ID: 11014644
[TBL] [Abstract][Full Text] [Related]
5. Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion.
Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Nomoto K
J Immunol; 1990 Sep; 145(5):1303-10. PubMed ID: 2143514
[TBL] [Abstract][Full Text] [Related]
6. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
[TBL] [Abstract][Full Text] [Related]
7. Role of the cytokine profiles produced by invariant natural killer T cells in the initial phase of cyclophosphamide-induced tolerance.
Onzuka T; Tomita Y; Shimizu I; Okano S; Yamada H; Yoshikai Y; Tominaga R
Transplantation; 2008 Nov; 86(9):1301-10. PubMed ID: 19005413
[TBL] [Abstract][Full Text] [Related]
8. Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice.
Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Maeda T; Ando T; Nomoto K
J Immunol; 1991 Mar; 146(5):1402-9. PubMed ID: 1671578
[TBL] [Abstract][Full Text] [Related]
9. Sequential analysis of anti-alpha Gal natural antibody-producing B cells in GalT knockout mice in cyclophosphamide-induced tolerance.
Shimizu I; Tomita Y; Iwai T; Kajiwara T; Okano S; Nomoto K; Tominaga R
Scand J Immunol; 2006 Jun; 63(6):435-43. PubMed ID: 16764697
[TBL] [Abstract][Full Text] [Related]
10. The requirement of intrathymic mixed chimerism and clonal deletion for a long-lasting skin allograft tolerance in cyclophosphamide-induced tolerance.
Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Nomoto K
Eur J Immunol; 1990 Sep; 20(9):2005-13. PubMed ID: 2209702
[TBL] [Abstract][Full Text] [Related]
11. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion.
Tomita Y; Nishimura Y; Harada N; Eto M; Ayukawa K; Yoshikai Y; Nomoto K
J Immunol; 1990 Dec; 145(12):4026-36. PubMed ID: 2147933
[TBL] [Abstract][Full Text] [Related]
12. Induction of permanent mixed chimerism and skin allograft tolerance across fully MHC-mismatched barriers by the additional myelosuppressive treatments in mice primed with allogeneic spleen cells followed by cyclophosphamide.
Tomita Y; Yoshikawa M; Zhang QW; Shimizu I; Okano S; Iwai T; Yasui H; Nomoto K
J Immunol; 2000 Jul; 165(1):34-41. PubMed ID: 10861032
[TBL] [Abstract][Full Text] [Related]
13. Interference with cyclophosphamide-induced skin allograft tolerance by cyclosporin A.
Nomoto K; Eto M; Yanaga K; Nishimura Y; Maeda T; Nomoto K
J Immunol; 1992 Oct; 149(8):2668-74. PubMed ID: 1401906
[TBL] [Abstract][Full Text] [Related]
14. Fractionated dosing of cyclophosphamide for establishing long-lasting skin allograft survival, stable mixed chimerism, and intrathymic clonal deletion in mice primed with allogeneic spleen cells.
Zhang QW; Mayumi H; Umesue M; Tomita Y; Nomoto K; Yasui H
Transplantation; 1997 Jun; 63(11):1667-73. PubMed ID: 9197364
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of cyclophosphamide-induced tolerance to IE-encoded alloantigens--evidence of clonal deletion in MHC antigen-reactive cells for skin allograft rejection.
Tomita Y; Ayukawa K; Yoshikai Y; Nomoto K
Transplantation; 1992 Mar; 53(3):602-12. PubMed ID: 1347961
[TBL] [Abstract][Full Text] [Related]
16. Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens.
Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nomoto K
J Exp Med; 1990 Jan; 171(1):97-113. PubMed ID: 2136907
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and limitations of natural killer cell depletion in cyclophosphamide-induced tolerance.
Shimizu I; Tomita Y; Okano S; Iwai T; Kajiwara T; Onzuka T; Tominaga R
Surg Today; 2007; 37(1):24-9. PubMed ID: 17186341
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced tolerance to allografts in mice. X. Augmentation of split tolerance in murine combinations disparate at both H-2 and non-H-2 antigens by the use of spleen cells from donors preimmunized with recipient antigens.
Mayumi H; Himeno K; Tokuda N; Fan JL; Nomoto K
Immunobiology; 1987 May; 174(3):274-91. PubMed ID: 3305319
[TBL] [Abstract][Full Text] [Related]
19. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide.
Mayumi H; Good RA
J Exp Med; 1989 Jan; 169(1):213-38. PubMed ID: 2642528
[TBL] [Abstract][Full Text] [Related]
20. Application of cyclophosphamide-induced tolerance in alpha1,3-galactosyltransferase knockout mice presensitized with Gal alpha 1-3Gal beta-4-GlcNAc antigens.
Onzuka T; Shimizu I; Tomita Y; Iwai T; Okano S; Tominaga R
Surg Today; 2008; 38(9):807-14. PubMed ID: 18751946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
